Northrop Grumman Q2 2026: The Strategic Moat Widens Amid A $7.6B Sentinel Surge (NYSE:NOC)
· seekingalpha.com
Northrop Grumman (NOC) rated BUY: nuclear triad role, strong Q2 2026, $104.7B backlog, Sentinel/B-21 growth, 30–72% upside. See more details here.
In this analysis, I examine Northrop Grumman's Q2 2026 performance through the lens of my broader investment thesis. For full context on the core framework, fun...